Divergent Interleukin-6 Responses to Hypoglycemia and Hyperglycemia in Adults With Type 1 Diabetes: Insights From Continuous Glucose Monitoring

Abstract

Keywords

interleukin-6 continuous glucose monitoring inflammation markers type 1 diabetes

Get full access to this article

View all access options for this article.

References

Zhao

Zhang

, et al. Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions. Medcomm (2020). 2024;5(4):e516.

Koshino

Schechter

Sen

, et al. Interleukin-6 and cardiovascular and kidney outcomes in patients with type 2 diabetes: new insights from CANVAS. Diabetes Care. 2022;45(11):2644-2652.

Zografou

Kouroupis

Dimakopoulos

Doukelis

Doumas

Koufakis

. Correlation between presepsin levels and continuous glucose monitoring metrics in infection-free individuals with type 1 diabetes. J Diabetes Sci Technol. 2025;19(1):277-278.

Jin

Zhang

Liu

, et al. The association between interleukin family and diabetes mellitus and its complications: an overview of systematic reviews and meta-analyses. Diabetes Res Clin Pract. 2024;210:111615.

Dotson

Freeman

Failing

Adler

. Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care. 2008;31(6):1222-1223.

Devaraj

Venugopal

Singh

Jialal

. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes. 2005;54(1):85-91.